FDA Inspection 1176378 — Akcea Therapeutics, Inc.
The FDA completed an inspection of Akcea Therapeutics, Inc. on Jun 15, 2022 in Carlsbad, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Carlsbad, CA (United States)
Additional details
Risk Evaluation and Mitigation Strategies (REMS)